Vycor Medical, Inc. filed a Form 8-K on November 16, 2026, furnishing a press release issued November 13, 2026, regarding financial results for the three and nine months ended September 30, 2026.

Key Highlights

  • Reporting period: Financial results cover the three and nine months ended September 30, 2026.
  • Press release date: The press release was issued on November 13, 2026, and is furnished as Exhibit 99.1.
  • Non-GAAP measures disclosed: The filing references non-GAAP Cash Operating Expenses and non-GAAP Cash Operating Loss, which exclude Depreciation and non-cash Stock Compensation.
  • Reconciliation included: According to the filing, the press release includes a reconciliation of non-GAAP financial measures to comparable GAAP financial measures.
  • Signed by: Peter C. Zachariou, Chief Executive Officer, on November 16, 2026.

Vycor Medical Furnishes Q3 2026 Earnings Press Release with Non-GAAP Disclosures

Vycor Medical, Inc. (OTCQB:VYCO) submitted a current report on November 16, 2026, disclosing that on November 13, 2026, the company issued a press release covering its financial results for the three and nine months ended September 30, 2026. The press release is attached to the filing as Exhibit 99.1. The filing notes that the information furnished under Item 2.02 "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934," and is not incorporated by reference into other regulatory filings unless expressly specified.

According to the filing, the press release includes references to non-GAAP financial measures, specifically non-GAAP Cash Operating Expenses and non-GAAP Cash Operating Loss. The company disclosed that these measures exclude Depreciation and non-cash Stock Compensation. The filing states that the company believes "these non-GAAP financial measures provide investors with insight into what is used by management to conduct a more meaningful and consistent comparison of our ongoing operating results and trends, compared with historical results." A reconciliation to the comparable GAAP financial measures is included in the press release, according to the filing.

The filing cautions that the non-GAAP measures "are not prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies," and that they "should not be considered in isolation or as a substitute for GAAP financial measures." The report was signed by Chief Executive Officer Peter C. Zachariou on November 16, 2026, on behalf of Vycor Medical, Inc., a Delaware corporation headquartered at 951 Broken Sound Parkway, Suite 320, Boca Raton, FL 33487.

What Was Disclosed

Vycor Medical furnished an 8-K on November 16, 2026, attaching a November 13, 2026 press release with financial results for the three and nine months ended September 30, 2026, along with non-GAAP measure disclosures and GAAP reconciliations.